Creek & River Revamps Board With New Internal and Outside Directors

CREEK & RIVER Co., Ltd. ( (JP:4763) ) just unveiled an announcement.

Creek & River Co., Ltd. announced executive personnel changes following a board resolution on April 9, 2026, with three current directors, including two outside directors, scheduled to retire at the conclusion of the annual general meeting of shareholders in late May. To reinforce its governance and expertise, the company has nominated Medical Principle Co., Ltd. president Shuro Ushio as an internal director and seasoned financial executive Tetsuya Yonehana, formerly a senior leader at Mitsubishi UFJ Financial Group and currently an advisor within the group, as an outside director, signaling a strategic strengthening of both operational and financial oversight.

These board changes indicate a shift toward leadership with deeper sector and financial-market experience, which could support the company’s long-term growth initiatives and capital strategy. Stakeholders may view the appointments as an effort to enhance corporate governance, risk management and strategic decision-making, particularly given Yonehana’s extensive background in banking and group CFO roles and Ushio’s operational track record in the medical staffing and services arena.

The most recent analyst rating on (JP:4763) stock is a Buy with a Yen1571.00 price target. To see the full list of analyst forecasts on CREEK & RIVER Co., Ltd. stock, see the JP:4763 Stock Forecast page.

More about CREEK & RIVER Co., Ltd.

Creek & River Co., Ltd. is a Japan-based company listed on the TSE Prime Market under securities code 4763. The group operates in professional services and content-related businesses, supporting industries such as media, healthcare and other specialist fields through talent management and related solutions.

Average Trading Volume: 63,637

Technical Sentiment Signal: Hold

Current Market Cap: Yen32.81B

For an in-depth examination of 4763 stock, go to TipRanks’ Overview page.